EUROFINS SCIENT (OTCMKTS:ERFSF - Get Free Report) saw a significant growth in short interest in the month of September. As of September 15th, there was short interest totaling 173,000 shares, a growth of 78.5% from the August 31st total of 96,900 shares. Based on an average daily volume of 1,700 shares, the short-interest ratio is currently 101.8 days. Based on an average daily volume of 1,700 shares, the short-interest ratio is currently 101.8 days.
Analyst Upgrades and Downgrades
Separately, Citigroup restated a "neutral" rating on shares of EUROFINS SCIENT in a research report on Friday, July 25th. One equities research analyst has rated the stock with a Strong Buy rating and five have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold".
Check Out Our Latest Report on ERFSF
EUROFINS SCIENT Price Performance
Shares of EUROFINS SCIENT stock traded down $2.05 on Friday, hitting $73.77. The company's stock had a trading volume of 1,197 shares, compared to its average volume of 1,234. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.26 and a quick ratio of 1.19. EUROFINS SCIENT has a 1 year low of $46.36 and a 1 year high of $83.02. The firm has a fifty day moving average price of $76.14 and a 200-day moving average price of $68.37.
EUROFINS SCIENT Company Profile
(
Get Free Report)
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider EUROFINS SCIENT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EUROFINS SCIENT wasn't on the list.
While EUROFINS SCIENT currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.